Aurinia Pharmaceuticals (AUPH) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

AUPH is expected to report earnings to rise 183.00% to 2 cents per share on October 31

Aurinia Pharmaceuticals AUPH Stock Earnings Reports

Q3'24

Est.

$0.03

Q2'24

Est.

$0.01

Q1'24

Beat

by $0.07

Q4'23

Missed

by $0.03

Q3'23

Beat

by $0.08

The last earnings report on August 01 showed earnings per share of 0 cents, meeting the estimate of 0 cents. With 2.67M shares outstanding, the current market capitalization sits at 1.04B.

View a ticker or compare two or three

Compare

AUPH

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For AUPH
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for AUPH (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

14315 118 Avenue

Phone

+1 250 708-4272

Employees

300

Web

https://www.auriniapharma.com